Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Global X Genomics And Biotechnology ETF C.GNOM


Primary Symbol: GNOM

The investment seeks to provide investment results that correspond generally to the price and yield performance before fees and expenses of the Solactive Genomics Index underlying index. The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchangelisted companies that are positioned to benefit from further advances in the field of genomic science and biotechnology as well as applications thereof collectively Genomics Biotechnology Companies as defined by Solactive AG the provider of the underlying index. The fund is nondiversified. The fund invests at least 80% of its total assets in the securities of the underlying index.


NDAQ:GNOM - Post by User

Global X Genomics And Biotechnology ETF > Just selling in rec market in BC and AB?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(33)
•••
Post by Calgary1111on Jun 21, 2021 12:37pm
270 Views
Post# 33420690

Just selling in rec market in BC and AB?

Just selling in rec market in BC and AB?Anyone know why we aren't selling this stuff on the Rec market all across Canada? The BC Gov site  where the stores by from to sell to the consumer was selling the Comatose Kush at a discount, so clearly we aren't selling out super fast any more. I'd assume that problem would go away if we had access to other Provinces in the rec market. Thoughts??
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities